| Literature DB >> 31108546 |
Zia S Pradhan1, Harsha L Rao1,2, Shivani Dixit1, Shruthi Sreenivasaiah1, Praveena G Reddy1, Jayasree P Venugopal1, Narendra K Puttaiah1,2, Sathi Devi1, Robert N Weinreb3, Kaweh Mansouri4,5, Carroll A B Webers6.
Abstract
Purpose: To compare the prevalence of choroidal microvasculature dropout (CMvD) in pseudoexfoliation glaucoma (PXG) and disease severity-matched primary open-angle glaucoma (POAG) eyes.Entities:
Mesh:
Year: 2019 PMID: 31108546 PMCID: PMC6528839 DOI: 10.1167/iovs.19-26844
Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN: 0146-0404 Impact factor: 4.799
FigureEvaluation of choroidal microvascular dropout (CMvD) in an eye with pseudoexfoliation glaucoma. (a) Choroidal slab of an optical coherence tomography angiography scan. (b) Optic disc margin (inner circle) and the region of parapapillary atrophy (outer outline) marked on the choroidal slab. (c) CMvD and the angular extent of CMvD marked on the slab.
Clinical Features, Visual Field Parameters, and OCT Measurements of the Participants in the PXG and POAG Groups
| Variables | |||
| Age, y | 66.3 ± 7.4 | 60.5 ± 13.6 | 0.04 |
| Sex, male:female | 21:12 | 23:11 | 0.73 |
| Hypertension, n (%) | 18 (54.6) | 17 (50.0) | 0.71 |
| Diabetes mellitus, n (%) | 13 (39.4) | 12 (35.3) | 0.73 |
| Spherical equivalent, D | 0.4 ± 1.5 | −0.2 ± 2.0 | 0.2 |
| Pseudophakia, n (%) | 11 (28.2) | 5 (12.8) | 0.09 |
| IOP at the scanning visit, mm Hg | 19.1 ± 6.4 | 17.0 ± 4.1 | 0.09 |
| No. of IOP lowering medications | 1.87 ±1.2 | 1.62 ± 1.1 | 0.34 |
| Type of IOP lowering medications | |||
| Beta-blockers, n (%) | 17 (43.6) | 18 (46.2) | 0.82 |
| Prostaglandin analogues, n (%) | 25 (64.1) | 23 (59.0) | 0.64 |
| Alpha agonists, n (%) | 18 (46.1) | 9 (23.1) | 0.03 |
| Carbonic anhydrase inhibitors, n (%) | 13 (33.3) | 12 (30.8) | 0.81 |
| Disc hemorrhage, n (%) | 7 (18.0) | 8 (20.5) | 0.77 |
| Mean deviation, dB | −12.1 ± 8.5 | −12.0 ± 8.3 | 0.96 |
| Visual field index, % | 68 ± 27 | 63 ± 27 | 0.36 |
| Type of visual field defect, n (%) | |||
| Nasal defect | 4 (10.3) | 4 (10.3) | |
| Parafoveal scotoma | 2 (5.1) | 2 (5.1) | 1 |
| Combined defect | 33 (84.6) | 33 (84.6) | |
| SSI, ONH scan of OCT | 50 ± 6 | 49 ± 7 | 0.85 |
| Peripapillary RNFL thickness, μm | 71 ± 15 | 74 ± 12 | 0.29 |
| Temporal sector RNFL thickness, μm | 61 ± 12 | 64 ± 12 | 0.32 |
| Superior sector RNFL thickness, μm | 88 ± 23 | 93 ± 22 | 0.27 |
| Nasal sector RNFL thickness, μm | 61 ± 15 | 63 ± 12 | 0.63 |
| Inferior sector RNFL thickness, μm | 81 ± 21 | 78 ± 19 | 0.63 |
| SSI, GCC scan of OCT | 60 ± 7 | 62 ± 8 | 0.44 |
| Average GCC thickness, μm | 75 ± 11 | 75 ± 10 | 0.86 |
| Superior GCC thickness, μm | 77 ± 12 | 80 ± 10 | 0.26 |
| Inferior GCC thickness, μm | 72 ± 13 | 69 ± 12 | 0.18 |
All values represent mean ± standard deviation unless specified. SSI, signal strength index.
OCT Angiography Measurements of the Participants in PXG and POAG Groups
| OCTA Parameters | |||
| RPC slab measurements | |||
| SSI, optic disc scan | 49 ± 6 | 50 ± 6 | 0.41 |
| Average peripapillary VD, % | 49.7 ± 8.2 | 51.3 ± 6.9 | 0.35 |
| Nasal sector VD, % | 47.6 ± 8.9 | 50.1 ± 7.6 | 0.20 |
| Inferonasal sector VD, % | 48.6 ± 9.9 | 50.2 ± 11.1 | 0.50 |
| Inferotemporal sector VD, % | 47.2 ± 10.6 | 44.1 ± 11.6 | 0.22 |
| Superotemporal sector VD, % | 51.0 ± 13.4 | 54.6 ± 11.0 | 0.20 |
| Superonasal sector VD, % | 49.7 ± 9.1 | 52.4 ± 8.7 | 0.19 |
| Temporal sector VD, % | 53.4 ± 8.0 | 54.7 ± 6.4 | 0.43 |
| Superficial macular measurements | |||
| SSI, macular scan | 58.9 ± 5.7 | 60.7 ± 6.2 | 0.19 |
| Average parafoveal VD, % | 44.8 ± 4.2 | 45.8 ± 3.7 | 0.33 |
| Superior parafoveal VD, % | 45.3 ± 4.6 | 45.6 ± 4.1 | 0.73 |
| Inferior parafoveal VD, % | 44.3 ± 4.7 | 44.8 ± 4.3 | 0.66 |
| Temporal sector VD, % | 44.9 ± 4.1 | 45.1 ± 4.1 | 0.87 |
| Superior sector VD, % | 45.6 ± 4.6 | 46.4 ± 4.0 | 0.43 |
| Nasal sector VD, % | 44.5 ± 4.7 | 45.2 ± 3.7 | 0.49 |
| Inferior sector VD, % | 44.0 ± 4.9 | 45.5 ± 4.7 | 0.21 |
| Choroidal slab measurements | |||
| Optic disc area, mm2 | 1.89 ± 0.45 | 2.06 ± 0.59 | 0.17 |
| Parapapillary atrophy area, mm2 | 1.63 ± 0.51 | 1.57 ± 0.52 | 0.60 |
| Presence of CMvD, n (%) | 18 (46.2) | 31 (79.5) | 0.002 |
| CMvD area, mm2 | 0.12 ± 0.13 | 0.11 ± 0.12 | 0.82 |
| Angular extent of CMvD, degrees | 49 ± 37 | 47 ± 34 | 0.83 |
All values represent mean ± standard deviation unless specified.
Factors Associated With the Presence of Choroidal Microvascular Dropout in Eyes With Open Angle Glaucoma
| Factors | ||||||
| Age | 0.97 (0.93–1.02) | 0.30 | ||||
| Male sex | 0.46 (0.17–1.29) | 0.14 | 0.32 (0.10–1.04) | 0.06 | 0.41 (0.13–1.29) | 0.13 |
| Hypertension | 0.62 (0.23–1.71) | 0.36 | ||||
| Diabetes mellitus | 0.69 (0.26–1.85) | 0.46 | ||||
| IOP at scanning visit | 0.94 (0.85–1.03) | 0.18 | 0.93 (0.85–1.01) | 0.11 | 0.94 (0.85–1.04) | 0.20 |
| PXF | 0.22 (0.08–0.62) | 0.004 | 0.24 (0.08–0.73) | 0.01 | 0.21 (0.07–0.64) | 0.006 |
| Disc hemorrhage | 0.87 (0.27–2.74) | 0.80 | ||||
| Disc area | 1.19 (0.51–2.75) | 0.69 | ||||
| Area of PPA | 0.91 (0.33–2.46) | 0.84 | ||||
| VF MD | 0.96 (0.91–1.02) | 0.19 | ||||
| VF VFI | 0.98 (0.96–1.00) | 0.06 | 0.97 (0.95–0.99) | 0.02 | ||
| Average RNFLT | 0.97 (0.93–1.01) | 0.20 | ||||
| Average GCCT | 0.95 (0.89–1.00) | 0.07 | 0.94 (0.89–0.99) | 0.01 | ||
| Peripapillary VD | 0.98 (0.92–1.05) | 0.60 | ||||
| Parafoveal VD | 0.99 (0.88–1.13) | 0.92 | ||||
CI, confidence interval; RNFLT, retinal nerve fiber layer thickness; GCCT, ganglion cell complex thickness.